<p><strong>Treatment of Asthma</strong>: Formoterol Fumarate is indicated for the treatment of asthma and in the prevention of bronchospasm only as concomitant&nbsp;therapy&nbsp;with a long-term asthma control medication, such as an inhaled&nbsp;corticosteroid, in adults and children 5 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma.<br />
<br />
<strong>Prevention of Exercise-Induced Bronchospasm</strong>: Formoterol Fumarate is also indicated for the acute prevention of exercise-induced bronchospasm in adults and children 5 years of age and older, when administered on an occasional, as-needed basis. Use of Formoterol Fumarate as a single agent for the prevention of exercise-induced bronchospasm may be clinically indicated in patients who do not have persistent asthma. In patients with persistent asthma, use of Formoterol Fumarate for the prevention of exercise-induced bronchospasm may be clinically indicated, but the treatment of asthma should include a long-term asthma control medication, such as an inhaled corticosteroid.<br />
<br />
<strong>Maintenance Treatment of Chronic Obstructive Pulmonary Disease</strong>: Formoterol Fumarate is indicated for the long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with Chronic Obstructive Pulmonary Disease including chronic bronchitis and&nbsp;emphysema.</p>